US Patent 11181527 Means and methods for monitoring inflammation
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+367 characters)
Article
Patent abstract
The application discloses methods, kits and a novel biomarker to detect and/or to prognose inflammation in patients. The diagnostic test is based on measuring the ratio of galactosylated and non-galactosylated specific N-glycans as obtained by enzymatic treatment of the total mixture of proteins present in a body fluid such as blood, serum or plasma.
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
111815270
Date of Patent
November 23, 2021
0Patent Application Number
157538800
Date Filed
August 26, 2016
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
111815270
Date of Patent
November 23, 2021
0Patent Application Number
157538800
Date Filed
August 26, 2016
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 25 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 11181527 Means and methods for monitoring inflammation
Infobox
Is a
Patent jurisdiction
Patent number
11181527
Date of patent
November 23, 2021
Patent application number
15753880
Date Filed
August 26, 2016
Patent primary examiner
Find more entities like US Patent 11181527 Means and methods for monitoring inflammation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
